(Japan) Introduction to Cancer Vaccines

Cancer vaccine therapy — including immune checkpoint inhibitors — is an important category of cancer immunotherapy. Current approaches target antigens such as MAGE, gp100, WT1, and NY-ESO using peptide vaccines, nucleic acid vaccines, and cellular vaccines. In recent years, particular attention has been given to neoantigen-based vaccines, which target highly specific tumor antigens unique to individual patients. Adjuvants that enhance immune response have also attracted significant research interest, especially as some earlier approaches showed limited efficacy and had their studies discontinued.

Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).

Figure 1

Figure 2

Figure 3

Figure 4